Table 1 Demographic data and baseline characteristics of the study participants
Parameter | Placebo | CLA |
|---|---|---|
n (female/male) | 13 (8/5) | 15 (5/10) |
Age (y), median (range) | 13 (7–18) | 13 (6–17) |
Age groups, n (% all participants) | ||
6–12 | 4 (14) | 6 (21) |
13–18 | 9 (32) | 9 (32) |
BMI (kg/m2)a, median (range) | 19.5 (15.3–29.0b) | 19.9 (14.7c-23.5) |
Major allergen, n (% group participants) | ||
Phl p1 | 6 (46) | 7 (47) |
Der p1 | 4 (31) | 5 (33) |
Fel d1 | 3 (23) | 3 (20) |
FEV1 % predicted, median (range) | 97 (70–126) | 95 (83–122) |